DPP4 and myocarditis: DPP-4 inhibition was reported to suppress transforming growth factor β (TGF-β) and α-smooth muscle actin (α-SMA) expression,5 and treatment with a DPP-4 inhibitor reduced fibrosis in a model of myocarditis in mice.6